Blood-Retinal Barrier

Advertisement

cGxPJobs Banner

Merck Reports Positive Phase 2b/3 BRUNELLO Results for Remigromig

RAHWAY, N.J. — September 24, 2026 Merck announced topline results from the pivotal Phase 2b/3 BRUNELLO study evaluating remigromig...

By cGxPwire Editor
September 26, 2026

Read More

Advertisement

cGxPJobs

Directory